Gene Query: SSR3

Dataset Description Geneva Score
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 52.53
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 40.42
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 39.64
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 38.04
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 36.81
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 35.41
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 30.19
Cleavage Factor Im as a key regulator of 3’ UTR length 29.67
Metastasis in triple-negative breast cancer 29.08
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 29.08
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 28.85
Dtx3L and Androgen Signaling in Prostate Cancer 27.89
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 27.75
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 26.98
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 26.26
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 25.06
An optimization system for isolating and sequencing of single human colon cancer cells 24.18
RIG-I and MDA5 fRIP during KSHV lytic reactivation 23.8
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 23.44
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 23.37
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 22.86
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 22.86
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 22.37
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 22.15
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 22.0
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 22.0
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 21.11
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 20.15
Co-transcriptional loading of RNA export factors shapes the human transcriptome 19.96
RNAseq of HEK293 cells after Chtop knockdown 19.96
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 19.91
Sensing self and nonself circular RNAs 18.99
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 18.92
Ribosomal footprinting of CN34-Parental and CN34-LM1a 18.82
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 18.52
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 18.44
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 18.44
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 18.34
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 17.98
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 17.98
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 17.83
RNA sequencing of matched nephrectomy samples [RNA-seq] 17.71
Genome-wide maps of H3K36me3 in ccRCC and RNA-seq of matched nephrectomy samples 17.71
Landscape of H3K4me3 in human CD19 cells 17.64
RNA-sequencing of human liver tissue 17.3
Ribosomal footprinting of MDA-Parental and MDA-LM2 16.68
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 16.5
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 16.33
Knockdown of ADNP in HCT116 colon cancer cells 16.05
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 16.04
Genome-wide analysis of Dengue virus 2 infected cells 16.01
The human blood-nerve barrier transcriptome 15.84
TOP2B disturbed the quality of human oocytes with advanced maternal age 15.33
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 15.31
Transcriptomic analysis of the HOTAIR-regulated genes 15.01
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 14.85
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 14.85
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 14.57
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 14.39
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 14.25
Loss of CREBBP results in gene expression repression in lymphoma cells 14.25
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 14.09
RNA transcriptome analysis during HSV-1 infection 13.88
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.82
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.82
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 13.71
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 13.7
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 13.59
NRDE2 negatively regulates nuclear exosome functions 13.55
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 13.54
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 13.4
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 13.32
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 13.31
3’ Uridylation Expands miRNA Target Repertoire 13.19
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 13.09
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 13.06
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 12.94
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 12.94
Be1 and Be2 B cells are transcriptionally distinct 12.92
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 12.81
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 12.65
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 12.65
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 12.6
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 12.6
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 12.6
Biological effect of chronic mistranslation in mammalian cells 12.39
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 12.35
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 12.3
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 12.22
Role of microRNAs in the interaction between Salmonella and the host cell 12.19
METTL3 promotes translation in human cancer cells 12.17
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 12.1
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 12.1
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 12.01
Reassessment of Exosome Composition 11.99
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 11.91
RNA-seq melanoma 11.86
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 11.82
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 11.79
Developmental stage specific chromosome architecture in human erythroid cells 11.79
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 11.72
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 11.72
Mapping interactions for the TNIP2 hub protein 11.67
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 11.66
DJ-1 is dispensable for human stem cell homeostasis 11.62
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 11.61
Novel Targeting of Transcription and Metabolism in Glioblastoma 11.57
Profiling of escape kinetics of viruses subjected to RNAi 11.56
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.51
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 11.28
Identification of global XBP1s target gene expression in human prostate cancer cells 11.21
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 11.01
The MEF2B Regulatory Network 10.94
The MEF2B Regulatory Network - RNA-seq data 10.94
Global Mapping of Human RNA-RNA Interactions 10.89
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 10.84
Identifying the molecular mode of action of itraconazole in colorectal cancer 10.78
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 10.7
Identification of transcription start sites for human A549 cell line using ReCappable-seq 10.68
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 10.54
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 10.54
Gene expression analysis of dengue-infected cells 10.53
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 10.53
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 10.45
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 10.45
MYC dependent mRNA translation shapes gene expression and cell biology 10.45
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 10.43
Morphological and molecular characterization of human dermal lymphatic collectors 10.42
Gene expression profiling of leukemia cells following asparagine depletion 10.36
CROP-Seq in Primary Human T Cells 10.33
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 10.29
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 10.1
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 10.1
Differetially expressed genes after hTR overexpression in U2OS cells 10.06
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 10.03
Exploring the RNA landscape of endothelial exosomes 10.02
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 9.97
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 9.93
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 9.93
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 9.93
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 9.82
Transcriptome of activated human and mouse MAIT cells 9.77
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 9.75
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 9.75
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 9.74
The pause-initiation limit restricts transcription activation in human cells 9.65
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 9.53
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.44
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 9.44
Role of XRN2 ribonucleolytic activity in RNA metabolism 9.43
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 9.38
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.36
An RNA-centric dissection of host complexes controlling flavivirus infection 9.36
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 9.33
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 9.31
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 9.31
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 9.22
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 9.22
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 9.14
Role for citron kinase in prostate cancer growth 9.13
Short and Long RNA sequencing of human mature erythrocytes 9.13
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 9.11
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 9.04
Fibroblasts in cholesteatoma activate osteoclasts. 9.04
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 9.02
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 9.0
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 8.84
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 8.84
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.81
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 8.77
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 8.77
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 8.62
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 8.6
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 8.47
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.42
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 8.38
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 8.37
RNA-seq of IL-4 stimulated human keratinocytes 8.37
BACH2 in human plasma cell fate decision 8.36
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.34
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 8.31
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 8.3
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 8.28
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.27
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 8.27
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 8.26
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 8.15
Measure transcript integrity using RNA-seq data 8.07
Landscape and variation of RNA secondary structure across the human transcriptome 8.04
Determination of tRNA aminoacylation levels by high throughput sequencing 8.0
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 7.99
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 7.94
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 7.91
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 7.9
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.9
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.9
Gene expression signatures of innate lymphoid cells from human blood 7.88
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 7.78
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 7.78
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 7.68
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 7.65
Exploring ILF2 regulatory genes by next-generation sequencing 7.64
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 7.62
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.59
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.59
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 7.58
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 7.57
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 7.54
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.51
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 7.45
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 7.43
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 7.4
Ribosomal protein RPL26 is the principal target of UFMylation 7.38
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 7.36
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 7.32
CDK12 mediated transcriptional regulation in U2OS cells 7.32
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 7.3
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 7.28
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 7.27
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 7.25
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 7.21
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 7.16
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 7.16
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 7.14
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 7.13
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.13
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 7.13
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 7.07
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 7.07
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 7.05
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.04
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 7.02
HEK293 Heat-shock experiment 7.02
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 6.99
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 6.99
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 6.96
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 6.96
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 6.91
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 6.91
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 6.91
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 6.88
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 6.85
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 6.8
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.73
Global analysis of enhancer targets: Mosaic-seq 6.73
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 6.68
Global expression profiles in cardiac progenitor cells generated by ISX-9 6.68
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 6.64
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 6.64
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 6.62
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 6.58
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 6.58
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 6.56
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 6.5
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 6.48
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 6.48
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.46
Transcriptomic profile of human embryonic renal corpuscles 6.44
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 6.44
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.43
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 6.4
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 6.36
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 6.28
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 6.25
RNA-sequencing of human tendon after injury 6.18
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 6.14
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 6.11
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 6.01
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 6.01
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 5.93
Human cell line and subcutaneous tumor 5.91
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 5.91
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 5.83
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 5.83
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 5.79
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.79
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 5.77
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 5.7
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 5.62
METTL3 and WTAP 5.61
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 5.58
MARCKS and lnc-MARCKS act as inflammation regulators 5.4
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 5.4
Gene expression regulated by CSA and CSB in neuroblastoma cell line 5.35
circRNA profile in hypopharyngeal cancer 5.32
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 5.3
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 5.25
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.24
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 5.21
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 5.19
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 5.18
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 5.17
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 5.09
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 5.07
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 5.01
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 5.01
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 4.96
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.91
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.83
MARS Seq data from human cortical organoids 4.8
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 4.79
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 4.76
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 4.72
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.71
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 4.7
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.65
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.64
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 4.63
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 4.63
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.53
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.53
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 4.43
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 4.25
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 4.25
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 4.25
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.22
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 4.21
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 4.13
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.12
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 4.11
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.1
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.1
RNA-Seq of PRMT1 overexpression ECA109 cells 3.98
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 3.82
Effect of BMP inhibition or stimulation of primary human keratinocytes 3.81
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 3.81
Transcriptional Signatures of Hypoxic and Inflammatory Renal Epithelial Injury 3.81
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.81
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 3.77
MicroRNA-125a-5p overexpression in human macrophages 3.74
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.73
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 3.69
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 3.68
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 3.68
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 3.63
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 3.61
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.58
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 3.57
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 3.56
Function and hormonal regulation of GATA3 in human first trimester placentation 3.55
RNA Seq of Alagille liver biopsies 3.54
Alagille_Nodder 3.54
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.54
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.46
The transcriptome of Kawasaki Disease arteritis 3.44
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.42
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.36
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.35
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 3.35
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.28
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.25
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 3.25
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.24
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.24
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.23
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.23
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 3.23
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.23
Gene expression profiling in metabolically heterogeneous human lung tumors 3.2
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.16
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.15
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 3.14
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 3.13
Dilated cardiomyopathy vs Myocarditis 3.1
Evaluating pre-clinical models for studying NASH driven HCC. 3.03
Comparative Analysis of Cas9 Activators Across Multiple Species 2.98
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.98
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.98
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.97
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.97
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 2.91
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 2.84
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.82
RNA-sequencing analysis of glucose and acetate regulated transcripts in glioblastoma cells 2.78
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.77
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.77
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.76
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.71
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 2.69
The DPYSL2 gene connects mTOR and schizophrenia 2.67
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.67
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.67
Transcriptome analysis reveals differential splicing events in IPF lung tissue 2.6
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.59
Induced DNA demethylation, genome instability and transcription 2.59
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 2.59
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 2.57
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 2.55
Zika virus directly infects human peripheral neurons and induces cell death 2.54
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 2.5
RNAseq in Alzheimer's Disease patients 2.48
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.47
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.47
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.47
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.44
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.4
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.4
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 2.39
Role of cervicovaginal microbiota in genital inflammation 2.35
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.3
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 2.29
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 2.28
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.27
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.25
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.24
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 2.22
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 2.21
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 2.17
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.14
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.09
Global response to chemotherapy-induced apoptosis 2.09
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.07
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.03
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 1.96
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 1.96
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.94
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.93
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.93
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.9
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 1.85
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.8
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.76
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.74
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.74
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.74
Dermal endothelial cells of type 2 diabetic patients 1.73
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.61
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.58
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.58
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.52
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.51
Interphase condensins regulate ligand-depedent enhancer activation 1.5
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.5
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 1.49
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.46
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.45
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.4
IMP3 regulated gene expression in breast cancer cells 1.39
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.37
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.35
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.35
Retinoic acid suppresses MYB in adenoid cystic carcinoma 1.34
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 1.34
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 1.34
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 1.33
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 1.32
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 1.26
Metabolism as an early predictor of DPSCs aging 1.23
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.14
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.13
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.13
Transcriptome analysis of kidney organoids 1.09
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.08
Transcriptomic profiling of human peripheral blood-derived mast cells 1.08
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.07
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 1.07
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.01
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.9
mRNA expression in human DAOY cells 0.83
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.83
In vitro modeling of human germ cell development using pluripotent stem cells 0.81
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.77
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.74
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.72
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 0.7
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 0.67
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 0.65
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 0.62
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.58
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 0.58
RNA-Seq from human ILC transitional populations 0.58
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.57
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.53
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.51
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.5
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.44
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.44
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 0.43
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.42
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.4
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.38
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.29
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 0.29
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.27
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.27
Gene expression alterations of pancreatic intraepithlial neoplasia 0.22
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.19
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.16
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.14
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.14
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.11
Aneuploidy-induced cellular stresses limit autophagic degradation. 0.1
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.09
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.08
Exogenous rescue of KLHL9 in SF210 cell line 0.07
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.03
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation